Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antacid plus proton pump inhibitor in functional dyspepsia
IRCT20230629058615N10Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Gaviscon in functional dyspepsia (FD) (2 arms), sponsored by Islamic Azad University. Started Oct 2025; status: completed.
02
Drugs
Gaviscon
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on IRCT20230629058615N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230629058615N10.